Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose.

Authors:
Jephte Y Akakpo Anup Ramachandran Steven C Curry Barry H Rumack Hartmut Jaeschke

Arch Toxicol 2022 02 3;96(2):453-465. Epub 2022 Jan 3.

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.

Acetaminophen (APAP) overdose can cause hepatotoxicity and even liver failure. N-acetylcysteine (NAC) is still the only FDA-approved antidote against APAP overdose 40 years after its introduction. The standard oral or intravenous dosing regimen of NAC is highly effective for patients with moderate overdoses who present within 8 h of APAP ingestion. However, for late-presenting patients or after ingestion of very large overdoses, the efficacy of NAC is diminished. Thus, additional antidotes with an extended therapeutic window may be needed for these patients. Fomepizole (4-methylpyrazole), a clinically approved antidote against methanol and ethylene glycol poisoning, recently emerged as a promising candidate. In animal studies, fomepizole effectively prevented APAP-induced liver injury by inhibiting Cyp2E1 when treated early, and by inhibiting c-jun N-terminal kinase (JNK) and oxidant stress when treated after the metabolism phase. In addition, fomepizole treatment, unlike NAC, prevented APAP-induced kidney damage and promoted hepatic regeneration in mice. These mechanisms of protection (inhibition of Cyp2E1 and JNK) and an extended efficacy compared to NAC could be verified in primary human hepatocytes. Furthermore, the formation of oxidative metabolites was eliminated in healthy volunteers using the established treatment protocol for fomepizole in toxic alcohol and ethylene glycol poisoning. These mechanistic findings, together with the excellent safety profile after methanol and ethylene glycol poisoning and after an APAP overdose, suggest that fomepizole may be a promising antidote against APAP overdose that could be useful as adjunct treatment to NAC. Clinical trials to support this hypothesis are warranted.

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00204-021-03211-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837711PMC
February 2022

Publication Analysis

Top Keywords

apap overdose
16
ethylene glycol
12
glycol poisoning
12
antidote apap
8
prevented apap-induced
8
treatment nac
8
methanol ethylene
8
nac
6
apap
5
fomepizole
5
overdose
5
damage promoted
4
metabolism phase
4
jnk oxidant
4
oxidant stress
4
stress treated
4
treated metabolism
4
hepatic regeneration
4
phase addition
4
addition fomepizole
4

Keyword Occurance

Similar Publications

essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy.

Authors:
Jing Zhao Kaixin Ding Manting Hou Yuanhua Li Xiaorong Hou Wenzhang Dai Zhiyong Li Jun Zhao Wenlong Liu Zhaofang Bai

Pharm Biol 2022 Dec;60(1):958-967

Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

Context: (Turcz.) Baill. (Magnoliaceae) essential oil (SCEO) composition is rich in lignans that are believed to perform protective effects in the liver. Read More

View Article and Full-Text PDF
December 2022
Similar Publications

Comparison of Two-Bag Versus Three-Bag N-Acetylcysteine Regimens for Pediatric Acetaminophen Toxicity.

Authors:
Sindhu Sudanagunta Alexa Camarena-Michel Stephanie Pennington Jan Leonard Christopher Hoyte George Sam Wang

Ann Pharmacother 2022 May 19:10600280221097700. Epub 2022 May 19.

University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Background: Acetaminophen overdose is a leading cause of liver failure, and a leading cause of pediatric poisoning requiring hospital admission. The antidote, N-acetylcysteine (NAC), is traditionally administered as a three-bag intravenous infusion. Despite its efficacy, NAC is associated with high incidence of nonallergic anaphylactoid reactions (NAARs). Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Hepatoprotective Effect of Nakai Adventitious Roots Extract by Regulating CYP450 and PPAR Signaling Pathway.

Authors:
Xiao-Long Jiang Pan-Yue Luo Yan-Ying Zhou Zhi-Hui Luo Yue-Jun Hao Ming-Zhi Fan Xiao-Han Wu Hao Gao Hui-Chang Bi Zhi-Bin Zhao Mei-Lan Lian Zhe-Xiong Lian

Front Pharmacol 2022 2;13:761618. Epub 2022 May 2.

Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Nakai is a traditional medicine that has been confirmed to exert effective antioxidant and anti-inflammatory functions, and is used for the treatment of different disorders. However, its potential beneficial effects on drug induced hepatotoxicity and relevant molecular mechanisms remain unclear. This study investigated the protective effect and further elucidated the mechanisms of action of on liver protection. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Failure of Risk Assessment Following Paracetamol Overdose - A Short Communication.

Authors:
Oulfa Boussetta-Charfi Cornélie Fanton D'Andon HoanVu Nguyen Barry H Rumack Manon Launay

Ther Drug Monit 2022 May 13. Epub 2022 May 13.

Laboratoire de Pharmacologie, Toxicologie et Gaz du Sang, CHU de Saint Etienne, France.

Introduction: The accepted treatment for patients with acetaminophen/paracetamol overdose includes risk assessment based on the Rumack-Matthew (R-M) nomogram. Inaccurate use of the nomogram may result in improper treatment. Clinicians were surveyed to determine their understanding and proper use of this risk assessment tool in practice. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.

Authors:
Ashwin Rao Jody A Rule Giuliana Cerro-Chiang Richard T Stravitz Brendan M McGuire Goo Lee Robert J Fontana William M Lee

Dig Dis Sci 2022 May 11. Epub 2022 May 11.

Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center at Dallas, 5959 Harry Hines Blvd. Ste. 420, Dallas, TX, 75390-8887, USA.

Background: While hepatitis A and B are well-known causes of acute liver failure (ALF), few well-documented cases of hepatitis C virus (HCV) infection (absent preexisting liver disease or other liver insults) have been described that result in ALF. We reviewed the Acute Liver Failure Study Group registry for evidence of HCV as a primary or contributing cause to ALF.

Methods: From January 1998 to January 2017, 2,332 patients with ALF (INR ≥ 1. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}